Novartis Invests in Stem Cell Therapy for Covid

(Bloomberg) -- Mesoblast Ltd. soars after getting a vote of confidence from large pharmaceutical backer Novartis AG on a stem cell medicine that was panned by U.S regulators just a month before.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.